Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Royalty_Pharma
Ramius LLC |
| gptkbp:acquisitionYear |
2010
|
| gptkbp:focus |
central nervous system disorders
|
| gptkbp:foundedYear |
1981
|
| gptkbp:headquartersLocation |
gptkb:San_Diego,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Cypress Bioscience
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
gptkb:Savella
gptkb:Cymbalta |
| gptkbp:status |
defunct
|
| gptkbp:stockSymbol |
CYPB
|
| gptkbp:tradedOn |
gptkb:NASDAQ
|
| gptkbp:bfsParent |
gptkb:InterWest_Partners
gptkb:Ryzolt |
| gptkbp:bfsLayer |
7
|